日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients

阿比特龙治疗药物监测在转移性去势抵抗性前列腺癌患者中的可行性和有效性

van der Kleij, Maud B A; Meertens, Marinda; Groenland, Stefanie L; Kordes, Sil; Bergman, Andries M; de Feijter, Jeantine M; Huitema, Alwin D R; Steeghs, Neeltje

Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223

对接受镭-223治疗的转移性去势抵抗性前列腺癌患者的疼痛、健康相关生活质量和镇痛药使用情况进行综合分析

Badrising, Sushil K; Louhanepessy, Rebecca D; van der Noort, Vincent; Kieffer, Jacobien; Coenen, Jules L L M; Hamberg, Paul; Beeker, Aart; Wagenaar, Nils; Lam, Marnix; Celik, Filiz; Loosveld, Olaf J L; Oostdijk, Ad; Zuetenhorst, Hanneke; de Feijter, Jeantine M; Dezentjé, Vincent O; Ras-van Spijk, Suzan; Vegt, Erik; Haanen, John B; van de Poll-Franse, Lonneke V; Zwart, Wilbert; Bergman, Andries M

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

术前伊匹单抗联合纳武单抗治疗局部区域晚期尿路上皮癌:NABUCCO 试验

Nick van Dijk #, Alberto Gil-Jimenez #, Karina Silina, Kees Hendricksen, Laura A Smit, Jeantine M de Feijter, Maurits L van Montfoort, Charlotte van Rooijen, Dennis Peters, Annegien Broeks, Henk G van der Poel, Annemarie Bruining, Yoni Lubeck, Karolina Sikorska, Thierry N Boellaard, Pia Kvistborg, D